Marfan syndrome, an insidious disease with an unexpected course
Abstract
Introduction: The study presents a 45-year-old male with Marfan syndrome admitted to the cardiac surgery
department with a suspected acute dissecting aneurysm of the ascending aorta involving distal thoracic and
abdominal aorta.
Case report: Patient was qualified for the surgical intervention and the Bentall procedure with valve On-X
and ascending aorta replacement with vascular prosthesis Gelweave was performed. Patient was readmitted
8 months later for reoperation due to the progress of the aortic arch aneurysm. During the redo surgery mediastinal
pseudoaneurysm originating from the anastomosis between vascular prosthesis and aortic arch was identified.
Aortic arch was replaced with vascular prosthesis Thoraflex. After 3 months the patient presented chronic cardiac
tamponade decompressed with substernal surgical access. 1 month later patient was readmitted with pseudoaneurysm
of the ascending aorta. Supracoronary section of the ascending aorta was replaced with a new Gelweave
vascular prosthesis and the bleeding that originated from the left coronary artery ostium was treated accordingly.
Marfan syndrome require multidisciplinary care and often multistage risk surgical treatments, including postoperative
bleeding or pseudoaneurysms. There are no clear data on the choice of valve prosthesis. Each time,
the surgeon must center the risk of hemorrhagic complications against the necessity for reoperation due to
degeneration of the biological prosthesis.
Keywords: Marfan syndromegenetic diseaseaortic aneurysmthoracoabdominalaortic dissectionthoracic surgerycardiovascular surgical procedures
References
- Isselbacher EM, Preventza O, Hamilton Black J, et al. Peer Review Committee Members. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 146(24): e334–e482.
- Zeigler SM, Sloan B, Jones JA. Pathophysiology and pathogenesis of Marfan syndrome. Adv Exp Med Biol. 2021; 1348: 185–206.
- Chung JJ, Gordon J, Atluri P. Type A dissections in patients with Marfan syndrome: When less is not more. J Thorac Cardiovasc Surg. 2017; 154(4): 1169–1170.
- Groth KA, Stochholm K, Hove H, et al. Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study). Am J Cardiol. 2018; 122(7): 1231–1235.
- Bachet J, Larrazet F, Goudot B, et al. When should the aortic arch be replaced in Marfan patients? Ann Thorac Surg. 2007; 83(2): S774–9; discussion S785.
- Price J, Magruder JT, Young A, et al. Long-term outcomes of aortic root operations for Marfan syndrome: A comparison of Bentall versus aortic valve-sparing procedures. J Thorac Cardiovasc Surg. 2016; 151(2): 330–336.
- Price J, Magruder JT, Young A, et al. Long-term outcomes of aortic root operations for Marfan syndrome: A comparison of Bentall versus aortic valve-sparing procedures. J Thorac Cardiovasc Surg. 2016; 151(2): 330–336.
- Chen Yu, Ma WG, Zheng J, et al. Total arch replacement and frozen elephant trunk for type A aortic dissection after Bentall procedure in Marfan syndrome. J Thorac Dis. 2018; 10(4): 2377–2387.
- Geisbuesch S, Schray D, Bischoff MS, et al. Frequency of reoperations in patients with Marfan syndrome. Ann Thorac Surg. 2012; 93(5): 1496–1501.
- Milewski RK, Habertheuer A, Bavaria JE, et al. Selection of prosthetic aortic valve and root replacement in patients younger than age 30 years. J Thorac Cardiovasc Surg. 2019; 157(2): 714–725.
- Puskas JD, Gerdisch M, Nichols D, et al. PROACT Investigators. Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement. J Am Coll Cardiol. 2018; 71(24): 2717–2726.